Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cilostazol and Probucol in Atherosclerosis Cerebral Infarction
NCT00823875Phase 4Completed
- Sponsor
- Otsuka Holdings
- Start
- Mar 2009
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cilostazol, probucol in cerebral infarction, atherosclerosis, sponsored by Otsuka Holdings. Started Mar 2009; status: completed.
02
Drugs
cilostazolprobucol
03
Conditions
cerebral infarctionatherosclerosis
Beyond the preview
Go deeper on NCT00823875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00823875.